Cohen scandal disrupts ex-Novartis CEO’s move to hedge fund board: WSJ

Former Novartis CEO Joe Jimenez—who authorized the ill-fated Michael Cohen deal—was set to join the board of a leading hedge fund, but the plans are …
Read the full story: FiercePharma: Pharma